A new study claims prostate cancer screenings significantly reduce deaths. Not everyone agrees
by Sharon Begley
Sep 04, 2017
3 minutes
An analysis of two influential studies of prostate cancer screening concludes that the much-debated test “significantly” reduces deaths from the disease, suggesting that current recommendations against routine PSA screening might be steering men away from a lifesaving procedure.
The , published Monday in Annals of Internal Medicine, drew wildly different reactions, as is often the case with research on PSA screenings. Some experts in cancer screening and statistics said its novel approach was “on shaky ground” and used a “completely unverifiable” methodology that they had “never seen before,” but others praised its “intriguing and
You’re reading a preview, subscribe to read more.
Start your free 30 days